According to a study in The Lancet, COVID-19 brought more than viral illness, lockdowns, and business disruptions, it also led to an increase in mental health problems. Researchers reported 76 million more cases of anxiety disorders and 53…
One of the most significant unanswered questions of the global pandemic is why some people experience mild symptoms while others become seriously ill and even die. The answer may be in our genes. Researchers from the United Kingdom have…
On the heels of the United Kingdom’s authorization of a competing medication by Merck, Pfizer announced that its own antiviral drug designed to treat COVID-19 shows promising results. According to the company’s clinical trial on 775 adults…
The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…
Many public health experts suggest that the COVID-19 pandemic will come to a close by the end of 2022, and while it will not disappear, the pandemic will mutate into an endemic disease. This change will mean that most people will have…
Federal legislation of interest to the oral health community was recently included in a hearing held by the U.S. House of Representatives’ Energy and Commerce Committee: the Oral Health Literacy and Awareness Act of 2021 (H.R. 4555).…
